A product image of a smart insole developed with a graphene sensing system that...
A product image of a smart insole developed with a graphene sensing system that can help detect early signs of foot ulcers before they form

Diabetic feet prevention

Smart insole detects signs of foot ulcer

Stevens Institute of Technology has signed an exclusive licensing agreement with Bonbouton, giving the company the right to use and further develop a graphene sensing system that detects early signs of foot ulcers before they form, so diabetic patients can access preventative healthcare and manage their health.

Complications from diabetes can make it difficult for patients to monitor their foot health. Chronically high levels of blood glucose can impair blood vessels and cause nerve damage. Patients can experience a lot of pain, or worse, can lose the feeling in their feet. Diabetes-related damage to blood vessels and nerves can lead to hard-to-treat infections such as ulcers. Ulcers that don’t heal can cause severe damage to tissues and bone and may require amputation of a toe, foot or part of a leg. advised.

Insole fits with Sneaker or dress shoes

Bonbouton’s smart insoles can be inserted into a sneaker or dress shoe to passively monitor the foot health of a person living with diabetes. The insoles sense the skin’s temperature, pressure and other foot health-related data, which can alert a patient and his or her healthcare provider healthcare provider, who can determine whether a treatment is needed. This simplifies patient self-monitoring and reduces the frequency of doctor visits. “I was inspired by two things: a desire to help those with diabetes and a desire to commercialize the technology,” said Bonbouton Founder and CEO Linh Le, who developed and patented the core graphene technology while pursuing a doctorate in chemical engineering at Stevens.

Billions of dollars can be saved in healthcare costs

Le started to create an insole that could help prevent diabetic ulcers after several personal incidents lead him to pursue preventative healthcare. “I am excited to realize the full potential the technology that will bring seamless preventative care to patients and save billions of dollars in healthcare costs.”

Stevens is a shareholder of Bonbouton (legally known as FlexTraPower) and co-owns two of the seven patents filed by the company.

20.11.2019

Read all latest stories

Related articles

Photo

Wearable against diabetic retinopathy

Smart contact lenses for diabetes diagnosis and treatment

Diabetes is called an incurable disease because once it develops, it does not disappear regardless of treatment in modern medicine. Having diabetes means a life-long obligation of insulin shots and…

Photo

Ultrasound monitoring

'Smart bra' to detect early-stage breast cancer

Students from EPFL in Switzerland teamed up with startup IcosaMed to develop the SmartBra – the first piece of smart clothing that can be used for cancer prevention. “Our smart-clothing…

Photo

Research award shortlist

Soft cardio-robot and 'Google Maps' of the heart face Big Beat Challenge

The British Heart Foundation (BHF) announced its shortlist of four research projects competing for a single £30 million award. The charity says it is one of many radical new approaches needed to…

Related products

Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH